Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Some people, however, may require medication such as an antihistamine, anti-inflammatory drug ... Some of these include: While many complementary and alternative medicines are used to treat acute and ...

Are you one of these people who loathes spending time outdoors at dusk as the weather warms and mosquitoes start biting?

The FDA last year turned away the companies' application and asked for additional efficacy data. Regeneron and Sanofi said the resubmission adds results from an additional Phase 3 study of Dupixent in ...

to twice-daily azelastine (an intranasal antihistamine), fluticasone propionate, the combination of the two, or placebo for 2 weeks during the allergy season; all treatments were administered as ...

Acute and chronic conditions typically differ in how they develop and how long they last. Broadly speaking, acute conditions occur suddenly, have immediate or rapidly developing symptoms, and are ...

Revenue: Total revenue was $2.1 million for the quarter ended September 30, 2024, comprised of $0.6 million in net product ...

Conclusions: This study demonstrated the benefit of a short course of a systemic low dosage of corticosteroids with and without antihistamine therapy during acute severe exacerbations of allergic ...

A New York woman, who was inspired to become a living donor, met the young boy she helped save at the Cleveland Clinic over ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...